The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 4,979
Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
Barnes, P. J., & Karin, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361506 · Cited by 4,669
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18921 · Cited by 3,503
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318921 · Cited by 3,436
Nitric oxide: an endogenous modulator of leukocyte adhesion.
Kubes, P., Suzuki, M., & Granger, D. N. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4651 · Cited by 3,029
Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?
Halliwell, B. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92211-x · Cited by 2,941
Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.
Griendling, K. K., Minieri, C. A., Ollerenshaw, J. D., & Alexander, R. W. (1994) · Circulation Research · doi:10.1161/01.res.74.6.1141 · Cited by 2,735
(2000) · PubMed · Cited by 2,095
Lindholm, L. H., Ibsen, H., Dahlöf, B., Devereux, R. B., Beevers, G., de Faire, U., Fyhrquist, F., Julius, S., Kjeldsen, S. E., Kristiansson, K., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08090-x · Cited by 1,560
Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor
Ichiki, T., Labosky, P. A., Shiota, C., Okuyama, S., Imagawa, Y., Fogo, A., Niimura, F., Ichikawa, I., Hogan, B. L. M., & lnagami, T. (1995) · Nature · doi:10.1038/377748a0 · Cited by 858
Venugopal, S. K., Devaraj, S., Yuhanna, I., Shaul, P., & Jialal, I. (2002) · Circulation · doi:10.1161/01.cir.0000033116.22237.f9 · Cited by 853
Tissue Angiotensin and Pathobiology of Vascular Disease: A Unifying Hypothesis
Dzau, V. J. (2001) · Hypertension · doi:10.1161/01.hyp.37.4.1047 · Cited by 750
Pueyo, M. E., Gonzalez, W., Nicoletti, A., Savoie, F., Arnal, J.-F., & Michel, J.-B. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.3.645 · Cited by 517
Griselli, M., Herbert, J., Hutchinson, W. L., Taylor, K. M., Sohail, M., Krausz, T., & Pepys, M. B. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.12.1733 · Cited by 508
Behrendt, D., & Ganz, P. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02963-6 · Cited by 499
C-Reactive Protein in Heart Failure: Prognostic Value and the Effect of Valsartan
Anand, I. S., Latini, R., Florea, V. G., Kuskowski, M. A., Rector, T., Masson, S., Signorini, S., Mocarelli, P., Hester, A., Glazer, R., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.508465 · Cited by 456
Cornwell, T. L., Arnold, E., Boerth, N. J., & Lincoln, T. M. (1994) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1994.267.5.c1405 · Cited by 455
Folli, F., Kahn, C. R., Hansen, H., Bouchie, J. L., & Feener, E. P. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119752 · Cited by 424
AT2Receptor Stimulation Increases Aortic Cyclic GMP in SHRSP by a Kinin-Dependent Mechanism
Gohlke, P., Pees, C., & Unger, T. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.349 · Cited by 395
Evidence for a Potent Antiinflammatory Effect of Rosiglitazone
Mohanty, P., Aljada, A., Ghanim, H., Hofmeyer, D., Tripathy, D., Syed, T., Al-Haddad, W., Dhindsa, S., & Dandona, P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032103 · Cited by 379
Self-citationDiep, Q. N., El Mabrouk, M., Cohn, J. S., Endemann, D., Amiri, F., Virdis, A., Neves, M. F., & Schiffrin, E. L. (2002) · Circulation · doi:10.1161/01.cir.0000016049.86468.23 · Cited by 345
Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions.
de Graaf, J. C., Banga, J. D., Moncada, S., Palmer, R. M., de Groot, P. G., & Sixma, J. J. (1992) · Circulation · doi:10.1161/01.cir.85.6.2284 · Cited by 337
Hollenberg, N. K., Fisher, N. D. L., & Price, D. A. (1998) · Hypertension · doi:10.1161/01.hyp.32.3.387 · Cited by 336
Ruiz-Ortega, M., Lorenzo, O., Rupérez, M., König, S., Wittig, B., & Egido, J. (2000) · Circulation Research · doi:10.1161/01.res.86.12.1266 · Cited by 331
Role of the Renin-Angiotensin System in Vascular Diseases: Expanding the Field
Ruiz-Ortega, M., Lorenzo, O., Rupérez, M., Esteban, V., Suzuki, Y., Mezzano, S., Plaza, J. J., & Egido, J. (2001) · Hypertension · doi:10.1161/hy1201.100589 · Cited by 308
Vincent, M. A., Barrett, E. J., Lindner, J. R., Clark, M. G., & Rattigan, S. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00021.2003 · Cited by 305
Zhang, H. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00183-2 · Cited by 296
Sola, S., Mir, M. Q. S., Cheema, F. A., Khan-Merchant, N., Menon, R. G., Parthasarathy, S., & Khan, B. V. (2005) · Circulation · doi:10.1161/01.cir.0000153272.48711.b9 · Cited by 282
Vaughan, D. E., Rouleau, J.-L., Ridker, P. M., Arnold, J. M. O., Menapace, F. J., & Pfeffer, M. A. (1997) · Circulation · doi:10.1161/01.cir.96.2.442 · Cited by 265
PPARγ-Activating Angiotensin Type-1 Receptor Blockers Induce Adiponectin
Clasen, R., Schupp, M., Foryst-Ludwig, A., Sprang, C., Clemenz, M., Krikov, M., Thöne-Reineke, C., Unger, T., & Kintscher, U. (2005) · Hypertension · doi:10.1161/01.hyp.0000168046.19884.6a · Cited by 257
Schieffer, B., Bünte, C., Witte, J., Hoeper, K., Böger, R. H., Schwedhelm, E., & Drexler, H. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.03.065 · Cited by 239
Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients
Koh, K. K., Ahn, J. Y., Han, S. H., Kim, D. S., Jin, D. K., Kim, H. S., Shin, M.-S., Ahn, T. H., Choi, I. S., & Shin, E. K. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00846-5 · Cited by 225
The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm
Dandona, P., Aljada, A., & Mohanty, P. (2002) · Diabetologia · doi:10.1007/s00125-001-0766-5 · Cited by 218
Self-citationGhanim, H., Garg, R., Aljada, A., Mohanty, P., Kumbkarni, Y., Assian, E., Hamouda, W., & Dandona, P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7309 · Cited by 218
Self-citationRueckschloss, U., Quinn, M. T., Holtz, J., & Morawietz, H. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000035392.38687.65 · Cited by 216
Dandona, P., Kumar, V., Aljada, A., Ghanim, H., Syed, T., Hofmayer, D., Mohanty, P., Tripathy, D., & Garg, R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021836 · Cited by 207
Self-citationTsutamoto, T., Wada, A., Maeda, K., Mabuchi, N., Hayashi, M., Tsutsui, T., Ohnishi, M., Sawaki, M., Fujii, M., Matsumoto, T., et al. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00594-x · Cited by 196
Kranzhöfer, R., Browatzki, M., Schmidt, J., & Kübler, W. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0543 · Cited by 192
Devaraj, S., Du Clos, T. W., & Jialal, I. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000168573.10844.ae · Cited by 177
Navalkar, S., Parthasarathy, S., Santanam, N., & Khan, B. V. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01138-4 · Cited by 171
Takeda, K., Ichiki, T., Tokunou, T., Funakoshi, Y., Iino, N., Hirano, K., Kanaide, H., & Takeshita, A. (2000) · Circulation · doi:10.1161/01.cir.102.15.1834 · Cited by 169
Skurk, T., Lee, Y., & Hauner, H. (2001) · Hypertension · doi:10.1161/01.hyp.37.5.1336 · Cited by 150
Valsartan, Blood Pressure Reduction, and C-Reactive Protein: Primary Report of the Val-MARC Trial
Ridker, P. M., Danielson, E., Rifai, N., & Glynn, R. J. (2006) · Hypertension · doi:10.1161/01.hyp.0000226046.58883.32 · Cited by 148
Interactions between the components of the human nadph oxidase: intrigues in the phox family
Leusen, J. H. W., Verhoeven, A. J., & Roos, D. (1996) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(96)90043-8 · Cited by 134
Yang, B., Phillips, M. I., Mohuczy, D., Meng, H., Shen, L., Mehta, P., & Mehta, J. L. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.9.1433 · Cited by 132
Petrie, M. C., Padmanabhan, N., McDonald, J. E., Hillier, C., Connell, J., & McMurray, J. J. V. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01111-1 · Cited by 129
Deletion of Angiotensin II Type 2 Receptor Exaggerated Atherosclerosis in Apolipoprotein E–Null Mice
Iwai, M., Chen, R., Li, Z., Shiuchi, T., Suzuki, J., Ide, A., Tsuda, M., Okumura, M., Min, L., Mogi, M., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.525550 · Cited by 128
Leiter, L. A., & Lewanczuk, R. Z. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.07.001 · Cited by 126
Skurk, T., van Harmelen, V., & Hauner, H. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000131266.38312.2e · Cited by 126
Nomura, S., Shouzu, A., Omoto, S., Nishikawa, M., Fukuhara, S., & Iwasaka, T. (2005) · Thrombosis Research · doi:10.1016/j.thromres.2005.04.008 · Cited by 88
Zahradka, P. C. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.2111 · Cited by 84
Weber, M. (1999) · American Journal of Hypertension · doi:10.1016/s0895-7061(99)00105-3 · Cited by 82
Mechanisms linking angiotensin II and atherogenesis
Strawn, W. B., & Ferrario, C. M. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200210000-00006 · Cited by 77
Khan, B. V., Navalkar, S., Khan, Q. A., Rahman, S. T., & Parthasarathy, S. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01615-1 · Cited by 72
Rosei, E. A., Rizzoni, D., Muiesan, M. L., Sleiman, I., Salvetti, M., Monteduro, C., & Porteri, E. (2005) · Journal of Hypertension · doi:10.1097/00004872-200502000-00027 · Cited by 71
Angiotensin Receptor Blockade Decreases Markers of Vascular Inflammation
Graninger, M., Reiter, R. A., Drucker, C., Minar, E., & Jilma, B. (2004) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000137160.76616.cc · Cited by 62
The role of the AT2 receptor in hypertension
Siragy, H. M. (2000) · American Journal of Hypertension · doi:10.1016/s0895-7061(00)00274-0 · Cited by 61
Serneri, G. G. N., Boddi, M., Modesti, P. A., Coppo, M., Cecioni, I., Toscano, T., Papa, M. L., Bandinelli, M., Lisi, G. F., & Chiavarelli, M. (2004) · Circulation Research · doi:10.1161/01.res.0000130944.49657.b8 · Cited by 57
Lauten, W. B., Khan, Q. A., Rajagopalan, S., Lerakis, S., Rahman, S. T., Parthasarathy, S., & Khan, B. V. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00161-9 · Cited by 36
Anan, F., Takahashi, N., Ooie, T., et al. (2004) · Metabolism · doi:10.1016/j.metabol.2003.12.021 · Cited by 36
Tsikouris, J. P., Suarez, J. A., Simoni, J. S., et al. (2004) · PubMed · Cited by 32
Angiotensin-receptor blocking agents and the peroxisome proliferator-activated receptor-γ system
Tuck, M. L. (2005) · Current Hypertension Reports · doi:10.1007/s11906-005-0019-y · Cited by 25
Nishikawa, H., Miura, S.-I., Shimomura, H., Tsujita, K., Okamura, K., Zhang, B., Iwata, A., Shirai, K., Matsuo, K., Arai, H., et al. (2005) · PubMed · Cited by 10
Cited by
Systemic manifestations and comorbidities of COPD
Barnes, P. J., & Celli, B. R. (2009) · European Respiratory Journal · doi:10.1183/09031936.00128008 · Cited by 1,820
The Role of Inflammatory Cytokines in Diabetic Nephropathy
Navarro-González, J. F., & Mora-Fernández, C. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007091048 · Cited by 932
Skeletal muscle inflammation and insulin resistance in obesity
Wu, H., & Ballantyne, C. M. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88880 · Cited by 695
Abundant Pleiotropy in Human Complex Diseases and Traits
Sivakumaran, S., Agakov, F., Theodoratou, E., Prendergast, J. G., Zgaga, L., Manolio, T., Rudan, I., McKeigue, P., Wilson, J. F., & Campbell, H. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.10.004 · Cited by 533
ANISMAN, H., MERALI, Z., & HAYLEY, S. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.01.004 · Cited by 337
Metadata
- Authors
- Dandona, P., Dhindsa, S., Ghanim, H., & Chaudhuri, A.
- Venue
- Journal of Human Hypertension
- Published
- 2006-11-09
- Volume
- 21
- Issue
- 1
- Pages
- 20-27
- ISSN
- 0950-9240 (ISSN-L)
- 1476-5527
- OpenAlex
- W2026849698
- Cited by
- 386
- References
- 66
- FWCI
- 10.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.